SILENCE THERAPEUTICS PLC

Analyst Reco. Silence Therapeutics plc

Equities

SLN

US82686Q1013

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
23 ^USD	+0.26%		+8.44%	+32.41%

17/05	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	MT
16/05	European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Boosts Price Target on Silence Therapeutics to $42 From $26 on Positive Data From Zerlasiran Study, Keeps Buy Rating	14/03	MT
Morgan Stanley Boosts Price Target on Silence Therapeutics to $45 From $29, Says Q4 Showed 'Meaningful Progress,' Keeps Overweight Rating	14/03	MT
BMO Capital Starts Silence Therapeutics With Outperform Rating, $67 Price Target	31/01	MT
HC Wainwright Adjusts Silence Therapeutics Price Target to $75 From $80, Maintains Buy Rating	17/11	MT
Chardan Adjusts Price Target on Silence Therapeutics to $26 From $29, Maintains Buy Rating	16/23/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW